Get the Stockscreener App
5.28
0.94%
-0.05
After Hours:
5.28
Entrada Therapeutics Inc stock is traded at $5.28, with a volume of 244.30K.
It is down -0.94% in the last 24 hours and up +2.33% over the past month.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
See More
Previous Close:
$5.33
Open:
$5.29
24h Volume:
244.30K
Relative Volume:
1.22
Market Cap:
$200.84M
Revenue:
$239.40M
Net Income/Loss:
$104.44M
P/E Ratio:
1.7838
EPS:
2.96
Net Cash Flow:
$-18.50M
1W Performance:
-0.19%
1M Performance:
+2.33%
6M Performance:
-52.94%
1Y Performance:
-64.47%
1-Day Range:
$5.20
$5.485
1-Week Range:
$5.08
$5.485
52-Week Range:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Name
Entrada Therapeutics Inc
Sector
Industry
Phone
857-305-1825
Address
ONE DESIGN CENTER PLACE, BOSTON
Compare TRDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
5.28 | 198.55M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | ROTH MKM | Buy |
| Jan-05-24 | Initiated | Oppenheimer | Outperform |
| Apr-03-23 | Initiated | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Stock (TRDA) Latest News
Analysts Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Price Target at $25.67 - MarketBeat
Entrada Therapeutics Inc. stock trend outlook and recovery pathPortfolio Update Report & Risk Adjusted Swing Trade Ideas - Newser
Real time social sentiment graph for Entrada Therapeutics Inc.Quarterly Profit Report & Growth Focused Entry Reports - Newser
What the charts say about Entrada Therapeutics Inc. todayEarnings Recap Summary & Daily Entry Point Alerts - Newser
Published on: 2025-09-12 13:57:08 - Newser
Using data filters to optimize entry into Entrada Therapeutics Inc.2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Detecting support and resistance levels for Entrada Therapeutics Inc.July 2025 Chart Watch & Free High Return Stock Watch Alerts - Newser
Has Entrada Therapeutics Inc. formed a bullish divergenceProduct Launch & Fast Entry Momentum Alerts - Newser
Entrada Therapeutics Inc. stock prediction for this weekPrice Action & Weekly Market Pulse Alerts - Newser
Can you recover from losses in Entrada Therapeutics Inc.July 2025 Final Week & Expert Approved Trade Ideas - Newser
Candlestick signals on Entrada Therapeutics Inc. stock todayJuly 2025 Analyst Calls & Verified Stock Trade Ideas - Newser
Applying Elliott Wave Theory to Entrada Therapeutics Inc.Watch List & High Accuracy Swing Entry Alerts - Newser
Is Entrada Therapeutics Inc. stock ready for a breakoutJuly 2025 Volume & Trade Opportunity Analysis Reports - Newser
Using R and stats models for Entrada Therapeutics Inc. forecastingRisk Management & Consistent Income Trade Recommendations - Newser
Price momentum metrics for Entrada Therapeutics Inc. explainedPrice Action & Daily Stock Momentum Reports - Newser
Is Entrada Therapeutics Inc. trending in predictive chart modelsRate Hike & Fast Entry Momentum Trade Alerts - Newser
what the charts say about entrada therapeutics inc. todayJuly 2025 Levels & Technical Entry and Exit Tips - Newser
What MACD and RSI say about Entrada Therapeutics Inc.Gap Down & High Conviction Buy Zone Picks - Newser
Trend analysis for Entrada Therapeutics Inc. this weekTrade Volume Summary & High Win Rate Trade Alerts - Newser
Published on: 2025-09-10 23:41:04 - Newser
Combining price and volume data for Entrada Therapeutics Inc.Stock Surge & Real-Time Market Sentiment Alerts - Newser
How hedge fund analytics apply to Entrada Therapeutics Inc. stockDip Buying & Daily Market Momentum Tracking - Newser
will entrada therapeutics inc. see short term momentumQuarterly Portfolio Report & Weekly Chart Analysis and Guides - Newser
67,016 Shares in Entrada Therapeutics, Inc. $TRDA Acquired by Nuveen LLC - MarketBeat
Applying chart zones and confluence areas to Entrada Therapeutics Inc.July 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
What MACD signals say about Entrada Therapeutics Inc.2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Quant Strategy Flags Entrada Therapeutics Inc. for EntryPortfolio Gains Summary & AI Powered Market Trend Analysis - beatles.ru
Can a trend reversal in Entrada Therapeutics Inc. lead to recoveryQuarterly Portfolio Report & Long-Term Capital Growth Strategies - Newser
price momentum metrics for entrada therapeutics inc. explainedJuly 2025 Decliners & Advanced Technical Signal Analysis - Newser
Reversal indicators forming on Entrada Therapeutics Inc. stockWall Street Watch & Real-Time Chart Breakout Alerts - Newser
Entrada Therapeutics Inc Stock (TRDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):